Anika Therapeutics (ANIK) Asset Utilization Ratio (2011 - 2026)
Anika Therapeutics (ANIK) posted quarterly Asset Utilization Ratio of 0.67 for Q2 2026, up 9.81% year-over-year from 0.61 in Q2 2025, and up 5.72% quarter-over-quarter from 0.63 in Q1 2026.
Anika Therapeutics (ANIK) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Asset Utilization Ratio for 16 consecutive years, with 0.67 the latest figure, recorded in Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 9.81% year-over-year to 0.67; the TTM figure through Jun 2026 stood at 0.67 (up 9.81% YoY), while the FY2025 annual figure was 0.57, up 13.33% from the prior year.
- Asset Utilization Ratio advanced to 0.67 in Q2 2026 per ANIK's latest filing, from 0.63 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.67 in Q2 2026 and bottomed at 0.33 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.43 in 2022.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio decreased 23.22% — and 2025, when it surged 71.04%.
- Anika Therapeutics' Asset Utilization Ratio stood at 0.33 in 2022, then increased by 23.5% to 0.4 in 2023, then surged by 36.91% to 0.55 in 2024, then rose by 7.58% to 0.59 in 2025, then advanced by 11.91% to 0.67 in 2026.
- Business Quant data shows ANIK's Asset Utilization Ratio at 0.67 in Q2 2026, 0.63 in Q1 2026, and 0.59 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Anika Therapeutics | 286.73 Mn | 248.32 Mn | 21.24 Mn | 0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.67 |
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.60 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.55 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.42 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.37 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.33 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.40 |